Last Updated: November 8, 2026

Details for Patent: 9,969,754

Name: Drug Patent Intelligence for US Patent 9969754
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which drugs does patent 9,969,754 protect, and when does it expire?

Patent 9,969,754 protects EVRYSDI and is included in two NDAs.

This patent has fifty-two patent family members in thirty-five countries.

Summary for Patent: 9,969,754

Title:	Compounds for treating spinal muscular atrophy
Abstract:	The present invention provides compounds of formula (I)
Inventor(s):	Hasane Ratni, Luke Green, Marla L. Weetall, Nikolai A. Naryshkin
Assignee:	Hoffmann La Roche Inc , PTC Therapeutics Inc
Application Number:	US15/351,267
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,969,754
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 9,969,754

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Genentech Inc	EVRYSDI	risdiplam	FOR SOLUTION;ORAL	213535-001	Aug 7, 2020		RX	Yes	Yes	9,969,754	⤷ Start Trial	Y	Y		TREATMENT OF SPINAL MUSCULAR ATROPHY	⤷ Start Trial
Genentech Inc	EVRYSDI	risdiplam	TABLET;ORAL	219285-001	Feb 11, 2025		RX	Yes	Yes	9,969,754	⤷ Start Trial	Y	Y		TREATMENT OF SPINAL MUSCULAR ATROPHY	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,969,754

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	3143025	⤷ Start Trial	301128	Netherlands	⤷ Start Trial
European Patent Office	3143025	⤷ Start Trial	PA2021010	Lithuania	⤷ Start Trial
European Patent Office	3143025	⤷ Start Trial	2021C/537	Belgium	⤷ Start Trial
European Patent Office	3143025	⤷ Start Trial	CA 2021 00037	Denmark	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.